Frederick W. Driscoll

CIK: 0001129890

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

LITS

Lite Strategy, Inc.

Director

CLRB

Cellectar Biosciences, Inc.

Director

CUE

Cue Biopharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

LITS
Lite Strategy, Inc.
Oct 22, 2026
Award(A)
Stock Option (Right to Buy)
Direct
100K shares-
CLRB
Cellectar Biosciences, Inc.
Jul 7, 2026
Award(A)
Stock option (right to buy)
Direct
25K shares-
LITS
Lite Strategy, Inc.
Nov 14, 2025
Award(A)
Stock Option (Right to Buy)
Direct
55K shares-
MEIP
MEI Pharma, Inc.
Jul 15, 2025
Award(A)
Stock Option (Right to Buy)
Direct
20K shares-
CLRB
Cellectar Biosciences, Inc.
Feb 14, 2025
Award(A)
Stock option (right to buy)
Direct
60K shares-
CUE
Cue Biopharma, Inc.
Jan 2, 2025
Award(A)
Stock Option (right to buy)
Direct
24.4K shares-

		Type	Shares	Price		Ownership
Oct 22, 2026	LITS Lite Strategy, Inc.	Award(A) Stock Option (Right to Buy)	100,000	-	-	Direct
Jul 7, 2026	CLRB Cellectar Biosciences, Inc.	Award(A) Stock option (right to buy)	25,000	-	-	Direct
Nov 14, 2025	LITS Lite Strategy, Inc.	Award(A) Stock Option (Right to Buy)	55,000	-	-	Direct
Jul 15, 2025	MEIP MEI Pharma, Inc.	Award(A) Stock Option (Right to Buy)	20,000	-	-	Direct
Feb 14, 2025	CLRB Cellectar Biosciences, Inc.	Award(A) Stock option (right to buy)	60,000	-	-	Direct
Jan 2, 2025	CUE Cue Biopharma, Inc.	Award(A) Stock Option (right to buy)	24,400	-	-	Direct

1-6 of 6 transactions

About DRISCOLL FREDERICK W

DRISCOLL FREDERICK W (SEC CIK 0001129890) files insider reports with the SEC as Director of Lite Strategy, Inc. (LITS), Director of Cellectar Biosciences, Inc. (CLRB) and Director of Cue Biopharma, Inc. (CUE).

Signal8 holds 6 ownership filings by DRISCOLL FREDERICK W, all Form 4s, filed between Jan 3, 2025 and Oct 26, 2026. Those filings report 6 transactions, from Jan 2, 2025 to Oct 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DRISCOLL FREDERICK W's filings is in SAN DIEGO, CA.

Recent filings by DRISCOLL FREDERICK W

Oct 22, 2026: Grant or award of LITS derivative securities (Form 4, code A).
Jul 7, 2026: Grant or award of CLRB derivative securities (Form 4, code A).
Nov 14, 2025: Grant or award of LITS derivative securities (Form 4, code A).
Jul 15, 2025: Grant or award of MEIP derivative securities (Form 4, code A).
Feb 14, 2025: Grant or award of CLRB derivative securities (Form 4, code A).

Other insiders filing for Lite Strategy, Inc. (LITS)

Glover Nicholas, Director
File Justin J., CEO, CFO and Secretary
Flynn James P, Director
Riezman Joshua, Director
Schornstein Alexander, 10% Owner
Lee Charles Benjamin, Director

How to read Form 4 transaction codes